TITLE:
An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents

CONDITION:
Bipolar Disorder

INTERVENTION:
Divalproex Sodium Extended-Release Tablets

SUMMARY:

      The purpose of this study is to determine the safety and effectiveness of Depakote ER
      (Divalproex Sodium Extended-Release Tablets) compared to placebo in the treatment of bipolar
      disorder, manic or mixed type in children and adolescents ages 10-17 years.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 10 Years to 17 Years
Criteria:

        INCLUSION CRITERIA

          -  Current primary diagnosis of bipolar I disorder, mania or mixed type

          -  Outpatient between 10 and 17 years of age

          -  Young Mania Rating Scale score greater than or equal to 20 during screening/washout
             and at Day 1

        EXCLUSION CRITERIA

          -  Axis I other than Attention Deficit Hyperactivity Disorder (ADHD), Obsessive
             Compulsive Disorder (OCD), Oppositional Defiant Disorder (ODD), Conduct Disorder
             (CD), Panic Disorder; or Axis II (e.g., personality disorder) that would interfere
             with compliance or confound interpretation of study results

          -  Current manic episode is drug-induced or secondary to a medical disorder (e.g.,
             anti-depressants, hyperthyroidism)

          -  Expected to require hospitalization for the current manic episode

          -  Participation in psychotherapy that was started within the past 3 months, or if any
             significant changes are anticipated

          -  Has taken atomoxetine or has taken allowed stimulant medication that has not been
             stable for at least 3 months prior to Day 1, or a dosage adjustment is expected
             during the study, or that may worsen mood symptoms

          -  Unable to swallow tablets

          -  Has received depot psychoactive medication within one inter-injection interval of Day
             1

          -  Urine toxicology screen is positive for phencyclidine (PCP), opiates, cocaine,
             barbiturates, benzodiazepines or amphetamines

          -  History of alcohol or substance dependence within past 3 mos. or substance abuse
             within past month

          -  History of failed treatment on adequate Depakote (DR or ER) for a manic episode
             within past 12 months

          -  Has taken Depakote (DR or ER) regularly for the current manic episode

          -  Has serious violent, homicidal, or suicidal ideation
      
